Who owns AEROVATE THERAPEUTICS INC?
- Ticker: AVTE
- CUSIP Number: 008064107
Tip: Access positions for across all investors
Analyze quarterly positions in Aerovate Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aerovate Therapeutics stock
Who bought or sold AEROVATE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 9.2M | $19M | 0% | Sep 2024 |
|
| Sofinnova Ventures | 3.8M | $7.9M | 0% | Sep 2024 |
|
| TCG Crossover Management | 2.2M | $3.7M | 2% | Jun 2024 |
|
| Atlas Venture Life Science Advisors | 1.8M | $3.0M | -12% | Jun 2024 |
|
| Deerfield Management Company | 1.4M | $3.0M | 0% | Sep 2024 |
|
| Vanguard Group | 1.1M | $1.8M | 64% | Jun 2024 |
|
| BlackRock | 983k | $1.6M | 39% | Jun 2024 |
|
| BlackRock | 954k | $2.0M | 100% | Sep 2024 |
|
| Baker Bros. Advisors | 629k | $1.3M | 0% | Sep 2024 |
|
| Affinity Asset Advisors | 600k | $1.3M | 200% | Sep 2024 |
|
| Octagon Capital Advisors | 465k | $973k | 0% | Sep 2024 |
|
| Opaleye Management | 440k | $920k | 0% | Sep 2024 |
|
| GSA Capital Partners | 414k | $865k | 227% | Sep 2024 |
|
| Ikarian Capital | 368k | $769k | 0% | Sep 2024 |
|
| Acadian Asset Management | 359k | $750k | 100% | Sep 2024 |
|
| State Street Corporation | 341k | $566k | 48% | Jun 2024 |
|
| Geode Capital Management | 292k | $610k | -8% | Sep 2024 |
|
| Two Sigma Investments | 279k | $463k | 1117% | Jun 2024 |
|
| Bank of America Corporation | 261k | $546k | 1262% | Sep 2024 |
|
| Verition Fund Management | 249k | $413k | 100% | Jun 2024 |
|
| Citigroup | 233k | $488k | 6484% | Sep 2024 |
|
| Northern Trust | 100k | $210k | 2% | Sep 2024 |
|
| Susquehanna International | 93k | $194k | -46% | Sep 2024 |
|
| Goldman Sachs Group | 91k | $151k | 100% | Jun 2024 |
|
| Alliancebernstein | 70k | $116k | 434% | Jun 2024 |
|
| Two Sigma Advisers | 70k | $116k | 795% | Jun 2024 |
|
| Ing Investment Management | 66k | $137k | 100% | Sep 2024 |
|
| Squarepoint Ops | 57k | $95k | 100% | Jun 2024 |
|
| Morgan Stanley | 52k | $86k | 97% | Jun 2024 |
|
| Citadel Advisors | 49k | $103k | 18% | Sep 2024 |
|
| Nan Fung Group Holdings | 48k | $100k | 0% | Sep 2024 |
|
| AQR Capital Management | 45k | $95k | 100% | Sep 2024 |
|
| Bank of New York Mellon | 42k | $87k | -12% | Sep 2024 |
|
| Nuveen Asset Management | 40k | $67k | 0% | Jun 2024 |
|
| Charles Schwab Investment Management | 29k | $61k | -44% | Sep 2024 |
|
| Quarry | 23k | $37k | 100% | Jun 2024 |
|
| ExodusPoint Capital Management | 21k | $44k | 100% | Sep 2024 |
|
| Barclays | 19k | $39k | 311% | Sep 2024 |
|
| Renaissance Technologies | 18k | $37k | 100% | Sep 2024 |
|
| Jane Street | 18k | $37k | -84% | Sep 2024 |
|
| Rhumbline Advisers | 13k | $28k | -12% | Sep 2024 |
|
| GG Group Ventures | 13k | $23k | 100% | Jun 2024 |
|
| SG Americas Securities | 11k | $23k | -94% | Sep 2024 |
|
| Dimensional Fund Advisors | 11k | $22k | -9% | Sep 2024 |
|
| Corsair Capital Management | 10k | $21k | 100% | Sep 2024 |
|
| Group One Trading | 9.9k | $21k | 253% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 7.4k | $16k | 52% | Sep 2024 |
|
| Jpmorgan Chase & Co | 6.0k | $13k | 3% | Sep 2024 |
|
| Federated Investors | 5.3k | $11k | 577% | Sep 2024 |
|
| Simplex Trading | 5.0k | $10k | -14% | Sep 2024 |
|
| Wells Fargo & Company | 4.9k | $10k | -3% | Sep 2024 |
|
| New York State Common Retirement Fund | 4.3k | $9.0k | 0% | Sep 2024 |
|
| Tower Research Capital | 4.1k | $6.9k | 101% | Jun 2024 |
|
| Qube Research & Technologies | 3.5k | $5.7k | 100% | Jun 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.2k | $4.6k | 0% | Sep 2024 |
|
| Royal Bank of Canada | 2.1k | $4.6k | 63% | Sep 2024 |
|
| California State Teachers Retirement System | 977.00 | $2.0k | 0% | Sep 2024 |
|
| Summit Investment Advisors | 772.00 | $1.6k | 0% | Sep 2024 |
|
| CWM | 497.00 | $1.0k | 307% | Sep 2024 |
|
| Amalgamated Bank | 347.00 | $999.984600 | 0% | Sep 2024 |
|
| Efficient Wealth Management | 258.00 | $0 | 100% | Sep 2024 |
|
| NISA Investment Advisors | 200.00 | $418.000000 | 809% | Sep 2024 |
|
| SRS Capital Advisors | 117.00 | $244.998000 | 0% | Sep 2024 |
|
| Jones Financial Companies, L.L | 100.00 | $206.000000 | 100% | Sep 2024 |
|
| Capital Performance Advisors | 80.00 | $167.000000 | 100% | Sep 2024 |
|
| Rothschild Investment | 70.00 | $145.999000 | 100% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 17.00 | $35.999200 | -100% | Sep 2024 |
|
| Sterling Capital Management | 13.00 | $26.999700 | 100% | Sep 2024 |
|
| Capital Advisors | 8.00 | $0 | 100% | Sep 2024 |
|
Who sold out of Aerovate Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cormorant Asset Management | Mar 2024 | 1.1M | $32M |
| Artal Group | Jun 2024 | 810k | $1.3M |
| Millennium Management | Jun 2024 | 672k | $1.1M |
| Ghost Tree Capital | Mar 2024 | 225k | $6.7M |
| Superstring Capital Management | Mar 2024 | 110k | $3.3M |
| Exome Asset Management | Mar 2024 | 99k | $2.9M |
| Warberg Asset Management | Jun 2024 | 67k | $111k |
| Fifth Lane Capital | Jun 2024 | 50k | $83k |
| Skandinaviska Enskilda Banken AB | Mar 2024 | 44k | $1.3M |
| Quest Partners | Jun 2024 | 33k | $55k |
| Cubist Systematic Strategies | Jun 2024 | 32k | $53k |
| Shay Capital | Mar 2024 | 25k | $727k |
| Prospera Financial Services | Jun 2024 | 24k | $40k |
| XTX Topco | Jun 2024 | 21k | $35k |
| ALPS Advisors | Mar 2024 | 20k | $577k |
| Parkwood | Jun 2024 | 19k | $31k |
| Caption Management | Jun 2024 | 16k | $27k |
| Values First Advisors | Jun 2024 | 15k | $26k |
| LMR Partners | Jun 2024 | 14k | $23k |
| Algert Coldiron Investors | Jun 2024 | 13k | $21k |
| Fortitude Family Office | Jun 2024 | 416.00 | $691.017600 |
| GAMMA Investing | Jun 2024 | 80.00 | $133.000000 |
| Pnc Financial Services | Jun 2024 | 11.00 | $18.000400 |